| Name | N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide |
|---|---|
| Synonyms |
Pilalisib analog (XL147 analog, S245408 analog)
PI3K inhibitor X SAR245408 XL147 analog XL-147 S245408 XL147;XL-147;S245408 S245408 (XL-147) N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide XL N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide Benzenesulfonamide, N-[3-(2,1,3-benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methyl XL147 analogue(PI3K inhibitor X) XL-147 derivative 2 XL 147 XL-147(S245408) PI3K inhibitorX XL147 analogue ,S1118 N-[3-(Benzo[c][1,2,5]thiadiazol-5-ylaMino)quinoxalin-2-yl]-4-MethylbenzenesulfonaMide XL147 //BP 9S)-Cinchonine N-(3-(Benzo[c][1,2,5]thiadiazol-5-ylamino)quinoxalin-2-yl)-4-methylbenzenes ulfonamide XL-147 XL147 ANALOG XL147 analogue XL147;XL XL147, >= Pilalisib analogue, 10 mM in DMSO |
| Description | Pilaralisib analogue (XL147 analogue) is a representative and selective PI3Kα inhibitor extracted from patent WO2012006552A1, Compound 147 in Table 1. |
|---|---|
| Related Catalog | |
| Target |
PI3K-alpha |
| References |
| Density | 1.538 |
|---|---|
| Molecular Formula | C21H16N6O2S2 |
| Molecular Weight | 448.52100 |
| Exact Mass | 448.07800 |
| PSA | 149.61000 |
| LogP | 5.06300 |
| Storage condition | -20℃ |